Effects of High‐ and Low‐Fat Meals on the Pharmacokinetics of Ozanimod, a Novel Sphingosine‐1‐Phosphate Receptor Modulator

Ozanimod (RPC1063) is an oral selective modulator of the sphingosine‐1‐phosphate 1 and 5 receptors under development for the treatment of relapsing multiple sclerosis and inflammatory bowel disease. The effects of high‐fat and low‐fat meals on the pharmacokinetics (PK) of a single oral dose of ozani...

Descripción completa

Detalles Bibliográficos
Autores principales: Tran, Jonathan Q., Hartung, Jeffrey P., Tompkins, Cindy‐Ann, Frohna, Paul A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6099448/
https://www.ncbi.nlm.nih.gov/pubmed/29125718
http://dx.doi.org/10.1002/cpdd.409

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6099448/
https://www.ncbi.nlm.nih.gov/pubmed/29125718
http://dx.doi.org/10.1002/cpdd.409

Ejemplares similares